美国 · SEC FORM 4
Liquidia Corp
LQDA · Nasdaq · CIK 0001819576 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
168 同一窗口内观察到的 Form 4 交易行
115 sales · 52 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director,TenPercentOwner; Director,TenPercentOwner,Other. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-05-19 · Caligan Partners LP; JOHNSON DAVID EDWARD.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 12,640,721
- 上期报告
- 12,377,976
- 日均成交量
- 3,291,757
- 回补天数
- 3.8
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Caligan Partners LP; JOHNSON DAVID EDWARD | 买入 (P) | Common Stock | 5,300 | USD 59.98 | USD 317,894 | SEC 申报 ↗ |
| 2024-09-12 | Manning Paul B | 买入 (P) | Common Stock | 337,078 | USD 8.90 | USD 2,999,994 | SEC 申报 ↗ |
| 2024-08-30 | Caligan Partners LP; JOHNSON DAVID EDWARD | 买入 (P) | Common Stock | 150,000 | USD 9.51 | USD 1,426,500 | SEC 申报 ↗ |
| 2023-12-14 | Manning Paul B | 买入 (P) | Common Stock | 279,330 | USD 7.16 | USD 2,000,003 | SEC 申报 ↗ |
| 2023-12-14 | JEFFS ROGER | 买入 (P) | Common Stock | 139,665 | USD 7.16 | USD 1,000,001 | SEC 申报 ↗ |
| 2023-12-14 | Caligan Partners LP; JOHNSON DAVID EDWARD | 买入 (P) | Common Stock, $0.001 par value per share ("Common Stock") | 1,117,318 | USD 7.16 | USD 7,999,997 | SEC 申报 ↗ |
| 2022-09-13 | Kaseta Michael | 买入 (P) | Common Stock | 8,000 | USD 5.99 | USD 47,920 | SEC 申报 ↗ |
| 2022-09-06 | JEFFS ROGER | 买入 (P) | Common Stock | 43,820 | USD 5.57 | USD 244,077 | SEC 申报 ↗ |
| 2022-09-06 | Caligan Partners LP; JOHNSON DAVID EDWARD | 买入 (P) | Common Stock, $0.001 par value per share ("Common Stock") | 250,000 | USD 5.62 | USD 1,405,000 | SEC 申报 ↗ |
| 2022-08-31 | Kaseta Michael | 买入 (P) | Common Stock | 1,927 | USD 4.90 | USD 9,442 | SEC 申报 ↗ |
| 2022-08-31 | JEFFS ROGER | 买入 (P) | Common Stock | 993 | USD 4.90 | USD 4,866 | SEC 申报 ↗ |
| 2022-08-31 | — | 买入 (P) | Common Stock | 2,160 | USD 4.90 | USD 10,584 | SEC 申报 ↗ |
| 2022-08-31 | — | 买入 (P) | Common Stock | 1,918 | USD 4.90 | USD 9,398 | SEC 申报 ↗ |
| 2022-05-31 | Kaseta Michael | 买入 (P) | Common Stock | 18,700 | USD 4.01 | USD 74,936 | SEC 申报 ↗ |
| 2022-05-25 | Caligan Partners LP; JOHNSON DAVID EDWARD | 买入 (P) | Common Stock, $0.001 par value per share ("Common Stock") | 79,400 | USD 3.40 | USD 269,960 | SEC 申报 ↗ |
Form 4 申报证据
291 transaction lines in the latest 365-day window; 624 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Schundler Russell | 卖出 (S) | Common Stock | 13,692 | USD 28.48 | USD 389,948 | SEC 申报 ↗ |
| 2026-10-12 | Saggar Rajeev | 卖出 (S) | Common Stock | 9,218 | USD 28.48 | USD 262,529 | SEC 申报 ↗ |
| 2026-10-12 | Moomaw Scott | 卖出 (S) | Common Stock | 8,863 | USD 28.48 | USD 252,418 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Schundler Russell | 卖出 (S) | Common Stock | 13,692 | USD 28.48 | USD 389,948 | SEC 申报 ↗ |
| 2026-10-12 | Saggar Rajeev | 卖出 (S) | Common Stock | 9,218 | USD 28.48 | USD 262,529 | SEC 申报 ↗ |
| 2026-10-12 | Moomaw Scott | 卖出 (S) | Common Stock | 8,863 | USD 28.48 | USD 252,418 | SEC 申报 ↗ |
| 2026-10-12 | Krepp Sarah | 卖出 (S) | Common Stock | 5,245 | USD 28.48 | USD 149,378 | SEC 申报 ↗ |
| 2026-10-12 | Khindri Sanjeev | 卖出 (S) | Common Stock | 1,101 | USD 28.48 | USD 31,356 | SEC 申报 ↗ |
| 2026-10-12 | Kaseta Michael | 卖出 (S) | Common Stock | 18,938 | USD 28.48 | USD 539,354 | SEC 申报 ↗ |
| 2026-10-12 | JEFFS ROGER | 卖出 (S) | Common Stock | 32,744 | USD 28.48 | USD 932,549 | SEC 申报 ↗ |
| 2026-10-12 | Boyle Dana | 卖出 (S) | Common Stock | 5,892 | USD 28.48 | USD 167,804 | SEC 申报 ↗ |
| 2026-10-12 | Adair Jason | 卖出 (S) | Common Stock | 7,301 | USD 28.48 | USD 207,932 | SEC 申报 ↗ |
| 2026-10-09 | Schundler Russell | 期权行权/转换 (M) | Common Stock | 10,167 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Saggar Rajeev | 期权行权/转换 (M) | Common Stock | 8,016 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Moomaw Scott | 期权行权/转换 (M) | Common Stock | 7,466 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Krepp Sarah | 期权行权/转换 (M) | Common Stock | 3,178 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Kaseta Michael | 期权行权/转换 (M) | Common Stock | 12,877 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | JEFFS ROGER | 期权行权/转换 (M) | Common Stock | 28,166 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Boyle Dana | 期权行权/转换 (M) | Common Stock | 3,178 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-09 | Adair Jason | 期权行权/转换 (M) | Common Stock | 10,248 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-05 | Bloch Stephen M | 卖出 (S) | Common Stock | 235,477 | USD 27.13 | USD 6,387,596 | SEC 申报 ↗ |
| 2026-09-14 | SINGH RAMAN | 卖出 (S) | Common Stock | 8,468 | USD 66.16 | USD 560,243 | SEC 申报 ↗ |
| 2026-09-14 | SINGH RAMAN | 期权行权/转换 (M) | Common Stock | 8,468 | USD 9.31 | USD 78,837 | SEC 申报 ↗ |
| 2026-09-11 | SINGH RAMAN | 卖出 (S) | Common Stock | 9,024 | USD 68.62 | USD 619,227 | SEC 申报 ↗ |
| 2026-09-11 | SINGH RAMAN | 期权行权/转换 (M) | Common Stock | 9,024 | USD 9.27 | USD 83,635 | SEC 申报 ↗ |
| 2026-09-01 | Krepp Sarah | 卖出 (S) | Common Stock | 274 | USD 67.76 | USD 18,566 | SEC 申报 ↗ |
| 2026-08-21 | Adair Jason | 卖出 (S) | Common Stock | 73,631 | USD 69.09 | USD 5,087,166 | SEC 申报 ↗ |
| 2026-08-21 | Adair Jason | 期权行权/转换 (M) | Common Stock | 31,799 | USD 11.00 | USD 349,839 | SEC 申报 ↗ |
| 2026-08-20 | Rielly-Gauvin Katherine | 卖出 (S) | Common Stock | 18,393 | USD 72.23 | USD 1,328,526 | SEC 申报 ↗ |
| 2026-08-20 | Rielly-Gauvin Katherine | 期权行权/转换 (M) | Common Stock | 18,393 | USD 2.54 | USD 46,700 | SEC 申报 ↗ |
| 2026-08-19 | Rielly-Gauvin Katherine | 卖出 (S) | Common Stock | 36,789 | USD 74.99 | USD 2,758,807 | SEC 申报 ↗ |
| 2026-08-19 | Rielly-Gauvin Katherine | 期权行权/转换 (M) | Common Stock | 36,789 | USD 2.54 | USD 93,407 | SEC 申报 ↗ |
| 2026-08-19 | Saggar Rajeev | 卖出 (S) | Common Stock | 50,000 | USD 74.06 | USD 3,703,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LQDA |
| CIK | 0001819576 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 624 transaction lines from 2020-11-18 to 2026-10-12 32 P purchase lines · 330 S sale lines · 262 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.